Back to Search
Start Over
One year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator. An observational DANBIO study
- Source :
- Glintborg, B, Sørensen, I J, Omerovic, E, Mehnert, F, Manilo, N, Danebod, K, Dorte Vendelbo, J, Nordin, H, Loft, A G, Hendricks, O, Chrysidis, S, Andersen, B L, Lillelund Raun, J, Lindegaard, H, Espesen, J, Højmark Jakobsen, S, Jensen Hansen, I M, Dalsgaard, E B, Pedersen, D D, Kristensen, S, Linauskas, A, Andersen, L S, Grydehøj, J, Krogh, N S & Hetland, M L 2018, ' One year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator. An observational DANBIO study ', EULAR 2018, Amsterdam, Netherlands, 13/06/2018-16/06/2018 . https://doi.org/10.1136/annrheumdis-2018-eular.2296, Publons, Glintborg, B, Sørensen, I J, Omerovic, E, Mehnert, F, Manilo, N, Danebod, K, Jensen, D V, Nordin, H, Loft, A G, Hendricks, O, Chrysidis, S, Andersen, B L, Lillelund Raun, J, Lindegaard, H M, Espesen, J, Højmark Jakobsen, S, Jensen Hansen, I M, Dalsgaard, E B, Pedersen, D D, Kristensen, S, Linauskas, A, Andersen, L S, Grydehøj, J, Krogh, N S, Hetland, M L & The Danbio registry and the Danish Departments of Rheumatology, Copenhagen, Denmark 2018, ' One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator. an observational danbio study ', Annals of the Rheumatic Diseases, vol. 77, no. Suppl. 2, FRI0103, pp. 595-596 . < https://ard.bmj.com/content/77/Suppl_2/595.2 >
- Publication Year :
- 2018
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Glintborg, B, Sørensen, I J, Omerovic, E, Mehnert, F, Manilo, N, Danebod, K, Dorte Vendelbo, J, Nordin, H, Loft, A G, Hendricks, O, Chrysidis, S, Andersen, B L, Lillelund Raun, J, Lindegaard, H, Espesen, J, Højmark Jakobsen, S, Jensen Hansen, I M, Dalsgaard, E B, Pedersen, D D, Kristensen, S, Linauskas, A, Andersen, L S, Grydehøj, J, Krogh, N S & Hetland, M L 2018, ' One year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator. An observational DANBIO study ', EULAR 2018, Amsterdam, Netherlands, 13/06/2018-16/06/2018 . https://doi.org/10.1136/annrheumdis-2018-eular.2296, Publons, Glintborg, B, Sørensen, I J, Omerovic, E, Mehnert, F, Manilo, N, Danebod, K, Jensen, D V, Nordin, H, Loft, A G, Hendricks, O, Chrysidis, S, Andersen, B L, Lillelund Raun, J, Lindegaard, H M, Espesen, J, Højmark Jakobsen, S, Jensen Hansen, I M, Dalsgaard, E B, Pedersen, D D, Kristensen, S, Linauskas, A, Andersen, L S, Grydehøj, J, Krogh, N S, Hetland, M L & The Danbio registry and the Danish Departments of Rheumatology, Copenhagen, Denmark 2018, ' One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator. an observational danbio study ', Annals of the Rheumatic Diseases, vol. 77, no. Suppl. 2, FRI0103, pp. 595-596 . < https://ard.bmj.com/content/77/Suppl_2/595.2 >
- Accession number :
- edsair.dedup.wf.001..88d69356f518442c91d4a515407229f4
- Full Text :
- https://doi.org/10.1136/annrheumdis-2018-eular.2296